Scientists around the world are racing to find a vaccine and a cure for the coronavirus.
Governments are pledging millions of dollars of taxpayers’ money for research in both public and private firms.
The global vaccine market is estimated to be worth nearly 60 billion dollars annually.
Pharmaceutical companies have been criticised in the past for being too slow in combatting diseases such as SARS and Ebola, and charging high prices for new drug treatments.
So what should be done to ensure they don’t put profit before saving lives?
Presenter: Maryam Nemazee
Guests:
Gustav Ando – Executive Director for the Economics and Country Risk Life Sciences practice, IHS Markit.
Gerald Posner – Investigative journalist and author of “Pharma: Greed, Lies and the Poisoning of America”
Andre Spicer – Professor of Organisational Behaviour, Cass Business School, City University of London
